ALEMBIC PHARMA Surges by 11%; BSE HEALTHCARE Index Up 1.7%
November 30, 2018 03:33 PM

ALEMBIC PHARMA share price has zoomed 11% and is presently trading at Rs 632.

Meanwhile, the BSE HEALTHCARE Index is at 14,344 (up 1.7%).

Among the top Gainers in the BSE HEALTHCARE Index today is ALEMBIC PHARMA (up 11.0%).

CAPLIN POINT (down 0.3%) and GRANULES INDIA (down 0.5%) are among the top losers today.

Over the last one year, ALEMBIC PHARMA has moved up from Rs 513 to Rs 632, registering a gain of Rs 119 (up 23.3%).

On the other hand, the BSE HEALTHCARE has moved up from 14,066 to 14,344, registering a gain of 278 points (up 1.9%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were IPCA LABS (up 48.9%), ABBOTT INDIA (up 45.9%) and BIOCON LTD (up 45.6%).

What About the Benchmark Indices?

The BSE Sensex is at 36,389 (up 0.2%).

The top gainers among the BSE Sensex stocks today are YES BANK (up 5.9%), WIPRO (up 3.3%) and M&M (up 2.4%). Other gainers include KOTAK MAH. BANK (up 2.0%) and HDFC (up 1.8%). The most traded stocks in the BSE Sensex are YES BANK and SUN PHARMA.

In the meantime, NSE Nifty is at 10,922 (up 0.2%). YES BANK (up 6.2%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 33,603 to 36,389, registering a gain of 2,786 points (up 7.9%).

ALEMBIC PHARMA Financial Update...

ALEMBIC PHARMA net profit stood at Rs 2 billion for the quarter ended September 2018, compared to a profit of Rs 1 billion a year ago. Net Sales rose 34.2% to Rs 11.3 billion during the period as against Rs 8.4 billion in July-September 2017.

For the year ended March 2018, ALEMBIC PHARMA reported 3.4% increase in net profit to Rs 4.2 billion compared to net profit of Rs 4.1 billion during FY17.

Revenue of the company grew 0.1% to Rs 31 billion during FY18.

The current Price to earnings ratio of ALEMBIC PHARMA, based on rolling 12 month earnings, stands at 22.8x.